Jagsonpal Pharmaceuticals Ltd Q1 FY2024 PAT up at Rs. 7.47 crore

Jagsonpal Pharmaceuticals Limited has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 62.150 crores during the period ended June 30, 2023 as compared to Rs. 58.010 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 7.479 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 5.602 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 2.85 for the period ended June 30, 2023 as compared to Rs. 2.14 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 62.150 crs	₹58.010 crs	7.14%
Net Profit	₹7.479 crs	₹5.602 crs	33.51%
EPS	₹2.85	₹2.14	33.18%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 62.150 crores during the period ended June 30, 2023 as compared to Rs.60.911 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.7.479 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.2.921 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.2.85 for the period ended June 30, 2023 as compared to Rs.1.12 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 62.150 crs	₹60.911 crs	2.03%
Net Profit	₹7.479 crs	₹2.921 crs	156.04%
EPS	₹2.85	₹1.12	154.46%

Shares of Jagsonpal Pharmaceuticals Limited was last trading in BSE at Rs. 467.40 as compared to the previous close of Rs. 477.55. The total number of shares traded during the day was 7500 in over 528 trades.

The stock hit an intraday high of Rs. 486.85 and intraday low of 459.15. The net turnover during the day was Rs. 3493329.00.

Source : Equity Bulls

Keywords

JagsonpalPharmaceuticals Q1FY24 ResultUpdate